BSE Live
Mar 10, 10:19Prev. Close
4772.55
Open Price
4785.50
Bid Price (Qty.)
4787.90 (3)
Offer Price (Qty.)
4797.15 (2)
NSE Live
Mar 10, 10:19Prev. Close
4769.50
Open Price
4803.50
Bid Price (Qty.)
4790.00 (1)
Offer Price (Qty.)
4792.00 (2)
| Balance Sheet of Pfizer (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 45.75 | 45.75 | 45.75 | 45.75 | 45.75 | |
| Total Share Capital | 45.75 | 45.75 | 45.75 | 45.75 | 45.75 | |
| Reserves and Surplus | 3,349.74 | 2,965.59 | 2,637.45 | 2,373.13 | 2,117.75 | |
| Total Reserves and Surplus | 3,349.74 | 2,965.59 | 2,637.45 | 2,373.13 | 2,117.75 | |
| Total Shareholders Funds | 3,395.49 | 3,011.34 | 2,683.20 | 2,418.88 | 2,163.50 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 2.50 | |
| Deferred Tax Liabilities [Net] | 0.00 | 2.23 | 14.58 | 17.56 | 28.24 | |
| Other Long Term Liabilities | 88.68 | 0.00 | 0.00 | 0.00 | 0.10 | |
| Long Term Provisions | 47.87 | 34.73 | 37.74 | 44.85 | 35.30 | |
| Total Non-Current Liabilities | 136.55 | 36.96 | 52.32 | 62.41 | 66.14 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 2.50 | 2.50 | 2.50 | 2.50 | 0.00 | |
| Trade Payables | 426.78 | 435.92 | 0.00 | 0.00 | 337.92 | |
| Other Current Liabilities | 386.37 | 390.90 | 888.42 | 718.98 | 265.46 | |
| Short Term Provisions | 57.71 | 62.37 | 63.52 | 58.19 | 55.03 | |
| Total Current Liabilities | 873.36 | 891.69 | 954.44 | 779.67 | 658.41 | |
| Total Capital And Liabilities | 4,405.40 | 3,939.99 | 3,689.96 | 3,260.96 | 2,888.05 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 214.52 | 71.43 | 81.50 | 83.27 | 98.33 | |
| Intangible Assets | 727.39 | 782.43 | 527.49 | 527.49 | 826.53 | |
| Capital Work-In-Progress | 0.76 | 0.00 | 1.04 | 3.92 | 3.27 | |
| Other Assets | 30.95 | 32.33 | 33.72 | 35.11 | 36.51 | |
| Fixed Assets | 973.62 | 886.19 | 951.36 | 906.11 | 964.64 | |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Assets [Net] | 0.62 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 31.90 | 31.77 | 43.30 | 32.12 | 30.63 | |
| Other Non-Current Assets | 351.01 | 305.36 | 278.58 | 271.42 | 260.31 | |
| Total Non-Current Assets | 1,357.15 | 1,223.32 | 1,273.24 | 1,209.65 | 1,255.58 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 430.59 | 386.66 | 297.06 | 321.90 | 360.68 | |
| Trade Receivables | 172.03 | 171.66 | 154.80 | 110.32 | 142.30 | |
| Cash And Cash Equivalents | 2,219.87 | 1,914.34 | 1,771.86 | 1,523.09 | 1,024.65 | |
| Short Term Loans And Advances | 3.52 | 5.38 | 28.04 | 27.00 | 24.70 | |
| OtherCurrentAssets | 222.24 | 238.63 | 164.96 | 69.00 | 80.14 | |
| Total Current Assets | 3,048.25 | 2,716.67 | 2,416.72 | 2,051.31 | 1,613.88 | |
| Total Assets | 4,405.40 | 3,939.99 | 3,689.96 | 3,260.96 | 2,888.05 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 254.60 | 219.12 | 471.89 | 498.58 | 689.38 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 41.13 | 78.64 | 148.87 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | 39.75 | 42.83 | 2.24 | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 19.11 | 19.11 | 19.11 | 19.11 | 19.11 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | 0.08 | |
| Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
10.02.2026
Pfizer Standalone December 2025 Net Sales at Rs 645.03 crore, up 19.9% Y-o-Y
13.11.2025
Pfizer Standalone September 2025 Net Sales at Rs 642.34 crore, up 9.13% Y-o-Y
20.05.2025
Pfizer Standalone March 2025 Net Sales at Rs 591.91 crore, up 8.28% Y-o-Y
01.02.2025
Pfizer Standalone December 2024 Net Sales at Rs 537.99 crore, down 0.37% Y-o-Y
19.10.2016
05.08.2016
03.01.2014
10.01.2011